{
  "ptid_time": "007_S_0128_2007-08-20",
  "img_path": "/data/qiuhui/data/adni/images/007_S_0128/2007-08-20/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 26,137 mm³, 17.0% above the reference mean. With a Z-score of 0.43 (66.5th percentile), this represents normal volume ; hippocampal volume measures 5,970 mm³, 22.3% below the reference mean. With a Z-score of -2.50 (0.6th percentile), this represents significant atrophy; whole brain volume measures 837,417 mm³, 18.6% below the reference mean. With a Z-score of -2.32 (1.0th percentile), this represents significant atrophy; entorhinal cortex volume measures 2,552 mm³, 34.4% below the reference mean. With a Z-score of -2.67 (0.4th percentile), this represents significant atrophy; fusiform gyrus volume measures 16,501 mm³, 9.4% below the reference mean. With a Z-score of -1.06 (14.5th percentile), this represents mild atrophy; middle temporal gyrus volume measures 14,732 mm³, 28.2% below the reference mean. With a Z-score of -2.51 (0.6th percentile), this represents significant atrophy. ",
  "text_data": "Age is 65.6 years. Gender is Female. Education: 20 years. MMSE: 28.0. APOEε4 alleles: 2.0. ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the hippocampus, whole brain, entorhinal cortex, and middle temporal gyrus—key regions affected in Alzheimer’s disease (AD). Despite the high MMSE score (28/30), the structural changes, particularly the hippocampal atrophy (Z-score -2.50) and APOE4 homozygosity (high genetic risk), strongly suggest neurodegenerative pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely prodromal AD given biomarker profile).  \n**Confidence:** **High** (due to concordance of imaging atrophy, APOE4 status, and subtle cognitive decline risk despite normal MMSE).  \n\n*Note: A follow-up with CSF biomarkers (e.g., Aβ42, p-tau) or amyloid PET would further clarify AD pathology.*",
  "timestamp": "2025-07-25T21:46:49.169379"
}